Discovering the relationships at the heart of biology to cure disease
London
Joined August 2020
- Tweets211
- Following538
- Followers1.5K
- Likes495
Pinned Tweet
We were deeply honoured to have Sir Paul Nurse @TheCrick join us to officially open our flagship integrated dry-wet lab in London's @KQ_London . Thank you Sir Paul Nurse for your inspirational speech and joining our CEO @welshmanofkent inaugurating our magnificent new home!
Relation retweeted
Weekend reading: A roadmap for TechBio disruption in drug discovery
Inner thoughts on how the industry works, and what could work for start ups entering the space. A blogpost with @Michael_JRYoung.
Relation retweeted
Yet another massive win for @DCVC-backed @RelationRx — and for future patients.
There’s imagining cures, and then there’s actually understanding biology at scale by uniting breakthrough capability lab-in-the-loop and deeply proprietary AI to drive real shots on goal. The latter is real #techbio, which is what we prefer to support, and why we are proud to have supported this brilliant team from the beginning.
Today is a major milestone for Relation.
We're expanding our collaboration with GSK to deploy MORGAN, our flagship cellular foundation model, at a new scale. This deal will bring up to $110 million in upfront and success-based milestone payments to Relation.
The patient is waiting.
bloomberg.com/news/articles/…
Relation retweeted
My take on @DCVC portfolio company @RelationRx’s new foundation model for cellular biology, called MORGAN—and the massive @gsk $110M deal to apply it to untreated or under-treated diseases.
"Building a general-purpose cellular foundation model is a hugely challenging project, and could prove to be the most audacious step forward in biological computation since the emergence of models like AlphaFold for protein structure prediction or Boltz for understanding molecular interactions."
More from @DCVC GP @jason_pontin on @RelationRx's next chapter 👇 (link in 🧵)
Relation retweeted
"Building a general-purpose cellular foundation model is a hugely challenging project, and could prove to be the most audacious step forward in biological computation since the emergence of models like AlphaFold for protein structure prediction or Boltz for understanding molecular interactions."
More from @DCVC GP @jason_pontin on @RelationRx's next chapter 👇 (link in 🧵)
Today is a major milestone for Relation.
We're expanding our collaboration with GSK to deploy MORGAN, our flagship cellular foundation model, at a new scale. This deal will bring up to $110 million in upfront and success-based milestone payments to Relation.
The patient is waiting.
bloomberg.com/news/articles/…
Relation today announced MORGAN (Multi-Omic Regulatory Genomics using Artificial Neural Networks), our flagship cellular foundation model designed to transform how new biology is understood and medicines are discovered.
globenewswire.com/news-relea…
Relation retweeted
When we first set up @RelationRx, we collaborated with the @GarvanInstitute to develop single-cell protocols to process cells embedded within human bone. It's great to see that work has now been published in @NatureGenet !
[Our internal dataset is actually now *substantially* larger ;) ]
Relation retweeted
Wow! This is so cool and way more fun than boring BioRender! Plus, developing fine motor skills through hand drawing and creativity without limitations in shapes or form! Try it out yourself here chat.figurelabs.ai/invitatio…
Relation retweeted
‘Lab-in-the-loop’ approach seeks to ensure targets are causally linked in bone health, immunology and metabolic disease.
longevity.technology/news/re…
#longevity #biotech #investment #osteoporosis #bonedisease #aging
Today we’re announcing a new collaboration between @RelationRx and @Novartis to accelerate the discovery of drug targets for atopic diseases. These conditions affect hundreds of millions of people globally, and better understanding their underlying biology is essential to delivering more effective medicines.
As our CEO David Roblin shared today in Bloomberg, too many programmes fail because we don’t yet understand the biology well enough at the start. This partnership brings together Novartis’ strength in immunology with Relation’s patient-derived data and AI platform to help change that.
The patient is waiting.
bloomberg.com/news/articles/…
globenewswire.com/news-relea…
Huge achievement by the Rosalind team at @RelationRx showing our now award-winning SOTA approach to DNA transformer models 🔥
Join us at @NeurIPSConf #NeurIPS and meet us in person: @wildtypehuman, @cristianregep, Lindsay Edwards, Rosie Rodriguez, Sara-Jane Dunn, and Alice Del Vecchio!
In the last few years I’ve built a DNA modelling team in industry @RelationRx. Our recent work just won 🏆 Best Paper at the @AI4D3 workshop at #NeurIPS, and we’ll be giving a talk. A few co-authors and I will be in San Diego this week and would love to connect with others passionate about DNA modelling.
🎤 Dec 6th, — San Diego Convention Center, Upper Level, Room 28A–E
🔗 Read the paper:
biorxiv.org/content/10.1101/…
Relation retweeted
In the last few years I’ve built a DNA modelling team in industry @RelationRx. Our recent work just won 🏆 Best Paper at the @AI4D3 workshop at #NeurIPS, and we’ll be giving a talk. A few co-authors and I will be in San Diego this week and would love to connect with others passionate about DNA modelling.
🎤 Dec 6th, — San Diego Convention Center, Upper Level, Room 28A–E
🔗 Read the paper:
biorxiv.org/content/10.1101/…
Relation retweeted
Heading to San Diego for #NeurIPS2025 , ping me if you want to chat on active learning, reinforcement learning, and applications of deep learning in genomics (single cell, spatial, etc).
Relation retweeted
Hiring someone for a very exciting project at the intersection of wet-lab and dry-lab. Generating spatial transcriptomics data and then analysing it. You need to be happy to get your hands dirty...!
Relation co-founder Jake Taylor-King (@wildtypehuman) speaking at @SlushHQ on how AI will transform drug discovery!
Relation retweeted
At @raais 2025, Benjamin Swerner Co-Founder and COO of @RelationRx reflected on why this century will be defined by two breakthroughs: building intelligence independent of humans and reducing the world’s disease burden.
Be part of the community at raais(dot)co, rsvps open!
Relation retweeted
This is an amazing line up! Come one and all :D
High-Content CRISPR Screening Conference
March 18-19, 2026 | Vienna, Austria
Abstract submission is now open! Don’t miss the chance to hear from an outstanding line-up of speakers and connect with leading researchers in the field.
Register now: perturb2026.bio/
ALT We invite researchers from across the globe to share their latest work and join the discussion shaping the future of CRISPR screening and genome editing. Scientific themes include * CRISPR-based screening strategies * Perturb-seq and CROP-seq methods * Computational analysis and data interpretation * AI models of human cells * Imaging-based CRISPR screens Date: March 18 & 19, 2026 Location: Vienna, Austria
Relation retweeted
We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place on March 18–19, 2026, in Vienna, Austria.
The registration is now open via the website:
perturb2026.bio/
Meet the Speaker: Jake P. Taylor-King
@wildtypehuman
@RelationRx
ALT Prior to co-founding Relation Therapeutics, Dr. Jake Taylor-King was an academic and industry researcher interested in company formation at the intersection of technology, computation, and the clinic. Previously an award-winning mathematician (G-Research prize, Lee Segel Prize), he has degrees from Bristol, Oxford, Cambridge, before later transitioning to biomedicine and genomics at ETH Zürich. Jake’s role as Chief Innovation Officer at Relation cuts across many functions, including leading an experimental technology development group, engaging in ML research, and designing clinical studies for patient tissue access.